Nuno Prego Ramos began his career in the pharmaceutical industry, leveraging an academic background in law and biochemistry. After leading the solid tumors unit at Novartis in Portugal, he co-founded and led CellmAbs, a biotech company that developed therapies later acquired by BioNTech in the biggest European transaction of 2024. Now, as the founder and CEO of Valvian, Nuno is driving biotech innovation in Portugal, with the goal of establishing the country as a center of excellence in life sciences and integrating AI into therapeutic development.